Silexon

Silexon is an emerging artificial intelligence-enabled technology company aiming to create an open AI platform for strategic cooperation to promote data-driven life science research and the drug development process, ultimately providing patients with more innovative drugs to meet unmet medical needs. We are the only AI-driven company that has established strategic partnerships with two leading CROs (namely Bioduro and Viva) in AI modeling and jointly enhancing each other's capabilities. Silexon has reached co-development agreements with approximately 20 partners, including but not limited to multinational corporations, publicly listed pharmaceutical companies, biotechnology firms, and regulatory agencies. On the AI4D™ platform, leveraging our interdisciplinary capabilities and expertise, we have developed and continuously optimized several generations of patented drug-target interaction models. Our AI/ML models integrate sequence-based, structural, interaction, and ligand-based information to efficiently identify targets and leads.